Consolidated EBITDA grew by 42.90% to Rs 285.76 crore in Q1 FY24 from Rs 199.97 crore in Q1 FY23. EBITDA margin improved to 23.2% in Q1 FY24 as against 19.4% in Q1 FY23.

As on 30 June 2023, the total borrowings less cash, bank balance and current investments was Rs 18.1 crore representing a net debt to equity ratio of 0.01. (Out of which, borrowings worth $ 43 million is foreign currency denominated).

Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, said: “We are pleased to report the highest-ever revenue on a quarterly basis with profitability sustaining at high levels. The international patient mix remains flat, and payor mix and speciality mix is in-line with the last quarter of the previous fiscal year.

Our overseas business at Cayman continues to contribute to overall performance, achieving the highest ever revenue and profitability on a quarterly basis, which is attributed to increased patient footfalls.

Our newly incorporated company Narayana Health Integrated Care (NHIC) has started on a positive note, and we are confident that it will have a significant impact to our overall business in future.”

Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 19 hospitals and 3 heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.

The scrip rose 0.83% to currently trade at Rs 1,023.20 on the BSE.